Weight Loss in Adults Using Semaglutide (Real-world Study)

Abroad (travel likely)Recruiting

Conditions

Overweight · Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Novo Nordisk Investigational Site, Seattle, Washington, United States
Novo Nordisk Investigational Site, London, United Kingdom

Study leads

Clinical Transparency (dept. 2834)
Study Director
Novo Nordisk A/S

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Predicting Difficult Intubation in Bariatric Surgery: Comparison of El Ganzouri Risk Index and Airway Ultrasound

Obesity & Overweight · Obesity Difficult Airway Airway Management · Obesity (Disorder)

Abroad (travel likely)Recruiting

Antalya, Turkey (Türkiye)

Ultrasound Assessment of Tongue Characteristics in Children and Adolescents With Obesity

Obesity & Overweight · Pediatric Obesity · Obstructive Sleep Apnea (OSA)

Abroad (travel likely)Recruiting

Brussels, Belgium · De Haan, Belgium

Breath Mass Spectrometry in Metabolic Syndrome and Metabolically Healthy Obesity

Metabolic Syndrome · Obesity & Overweight · Metabolically Healthy Obesity

Abroad (travel likely)Recruiting

Moscow, Russia

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Obesity & Overweight

Abroad (travel likely)RecruitingPHASE3

Shanghai, China